Butalbital-Containing Products
Effective September 17, 2014, changes to 902 KAR 55:045 were
finalized, and it was adapted to mirror the exempt prescription product
list published in Title 21 Code of Federal Regulations 1308.32,
with the exception of butalbital-containing products.
What this means:
♦ All butalbital-containing products are Schedule III controlled
substances (CS).
♦ Prescriptions for butalbital-containing products must be reported
to the Kentucky All Schedule Prescription Electronic
Reporting system.
♦ Physician assistants (PAs) cannot prescribe butalbitalcontaining
products.
♦ Refills are no longer valid for any prescription written with
refills for butalibal-containing products by a PA prior to September
17, 2014.
♦ Advanced practice registered nurses (APRNs) must have a valid
DEA registration to prescribe butalbital-containing products.
♦ Refills are no longer valid for any prescription written with
refills for butalbital-containing products by an APRN without
a DEA registration prior to September 17, 2014.
♦ APRNs can only prescribe a 30-day supply and cannot authorize
refills since butalbital-containing products are Schedule
III CS.
♦ Any physician who has his or her license restricted to not allow
the prescribing of CS cannot prescribe butalbital-containing
products, and any refill authorized by the above physician on
or after September 17, 2014, is no longer valid.
quoted from Kentucky Board of Pharmacy December 2014 Newsletter
Effective September 17, 2014, changes to 902 KAR 55:045 were
finalized, and it was adapted to mirror the exempt prescription product
list published in Title 21 Code of Federal Regulations 1308.32,
with the exception of butalbital-containing products.
What this means:
♦ All butalbital-containing products are Schedule III controlled
substances (CS).
♦ Prescriptions for butalbital-containing products must be reported
to the Kentucky All Schedule Prescription Electronic
Reporting system.
♦ Physician assistants (PAs) cannot prescribe butalbitalcontaining
products.
♦ Refills are no longer valid for any prescription written with
refills for butalibal-containing products by a PA prior to September
17, 2014.
♦ Advanced practice registered nurses (APRNs) must have a valid
DEA registration to prescribe butalbital-containing products.
♦ Refills are no longer valid for any prescription written with
refills for butalbital-containing products by an APRN without
a DEA registration prior to September 17, 2014.
♦ APRNs can only prescribe a 30-day supply and cannot authorize
refills since butalbital-containing products are Schedule
III CS.
♦ Any physician who has his or her license restricted to not allow
the prescribing of CS cannot prescribe butalbital-containing
products, and any refill authorized by the above physician on
or after September 17, 2014, is no longer valid.
quoted from Kentucky Board of Pharmacy December 2014 Newsletter
No comments:
Post a Comment